TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways
暂无分享,去创建一个
I. Frahm | P. Brouckaert | W. Béguelin | Wendy Béguelin | Peter Brouckaert | M. Rivas | Cecilia J. Proietti | P. Elizalde | R. Schillaci | Mariana Salatino | Roxana Schillaci | S. Sapia | Eduardo H. Charreau | Patricia V. Elizalde | Martín A. Rivas | Romina Carnevale | Cinthia Rosemblit | Isabel Frahm | Sandra Sapia | R. Carnevale | M. Salatino | E. Charreau | C. Rosemblit | Romina P. Carnevale
[1] W. Buurman,et al. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein. , 1994, The Journal of infectious diseases.
[2] A. Molinolo,et al. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. , 1986, Cancer letters.
[3] P. Vandenabeele,et al. Identification of Tumor Necrosis Factor (TNF) Amino Acids Crucial for Binding to the Murine p75 TNF Receptor and Construction of Receptor-selective Mutants* , 2001, The Journal of Biological Chemistry.
[4] Debajit K. Biswas,et al. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis , 2004 .
[5] A. Baldwin,et al. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.
[6] T. Hammond,et al. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. , 1998, Cancer research.
[7] D. Polk,et al. Conversion of TNFα from Antiproliferative to Proliferative Ligand in Mouse Intestinal Epithelial Cells by Regulating Mitogen-Activated Protein Kinase , 1999 .
[8] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[9] W. Shea-Eaton,et al. TNFα induces NFκB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells , 2001 .
[10] G. Murphy,et al. Functional Significance of MMP-9 in Tumor Necrosis Factor-Induced Proliferation and Branching Morphogenesis of Mammary Epithelial Cells. , 2000, Endocrinology.
[11] A. Molinolo,et al. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma , 1995, Breast Cancer Research and Treatment.
[12] C. Croce,et al. TNF‐α signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF‐α receptor , 2002 .
[13] Robert C. Bast,et al. Tumor Necrosis Factor α as an Autocrine and Paracrine Growth Factor for Ovarian Cancer: Monokine Induction of Tumor Cell Proliferation and Tumor Necrosis Factor α Expression , 1993 .
[14] C. M. Hansen,et al. Sensitization to TNF‐induced apoptosis by 1,25‐dihydroxy vitamin D3 involves up‐regulation of the TNF receptor 1 and cathepsin B , 2001, International journal of cancer.
[15] M. Karin. Nuclear factor-κB in cancer development and progression , 2006, Nature.
[16] D. Goeddel,et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.
[17] C. Clarke,et al. Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.
[18] A. Lin,et al. The Absence of NF-κB-Mediated Inhibition of c-Jun N-Terminal Kinase Activation Contributes to Tumor Necrosis Factor Alpha-Induced Apoptosis , 2002, Molecular and Cellular Biology.
[19] J. Suttles,et al. Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Abrogates Ligand-mediated Activation of Nuclear Factor-κB and of Mitogen-activated Protein Kinases in Macrophages* , 2001, The Journal of Biological Chemistry.
[20] W. Liao,et al. The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.
[21] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[22] G. Stark,et al. Distinct Roles of the IκB Kinase α and β Subunits in Liberating Nuclear Factor κB (NF-κB) from IκB and in Phosphorylating the p65 Subunit of NF-κB* , 2001, The Journal of Biological Chemistry.
[23] T. Giordano,et al. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF , 2007, Nature Medicine.
[24] M. Gerritsen,et al. Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo* , 1997, The Journal of Biological Chemistry.
[25] Yan Tang,et al. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. , 2004, International journal of oncology.
[26] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[27] Robert J. Moore,et al. An Anti-Tumor Necrosis Factor-α Antibody Inhibits the Development of Experimental Skin Tumors , 2003 .
[28] P. Elizalde,et al. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. , 2001, Experimental cell research.
[29] W. Lesslauer,et al. Tumor Necrosis Factor Receptors (Tnfr) in Mouse Fibroblasts Deficient in Tnfr1 or Tnfr2 are Signaling Competent and Activate the Mitogen-activated Protein Kinase Pathway with Differential Kinetics* , 1996, The Journal of Biological Chemistry.
[30] M. Marino,et al. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. , 1999, Cancer research.
[31] M. Karin,et al. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression , 2004 .
[32] Young Chul Park,et al. A Novel Mechanism of TRAF Signaling Revealed by Structural and Functional Analyses of the TRADD–TRAF2 Interaction , 2000, Cell.
[33] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[34] R. Heller,et al. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. , 1998, Journal of immunology.
[35] T. van der Poll,et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. , 1997, Blood.
[36] I. Frahm,et al. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity , 2004, Oncogene.
[37] Chih‐Chung Lin,et al. Involvement of p42/p44 MAPK, JNK, and NF‐κB in IL‐1β‐induced ICAM‐1 expression in human pulmonary epithelial cells , 2005 .
[38] M. Hung,et al. HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway* , 2000, The Journal of Biological Chemistry.
[39] M. Ricote,et al. Role of tumor necrosis factor‐α and its receptors in human benign breast lesions and tumors (in situ and infiltrative) , 2006 .
[40] D. Goeddel,et al. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75 , 1995, The Journal of experimental medicine.
[41] Marty W. Mayo,et al. Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38* , 2001, The Journal of Biological Chemistry.
[42] Y. Geng,et al. Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.
[43] M. Ip,et al. Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. , 1996, Endocrinology.
[44] M. Karin,et al. Inhibition of JNK activation through NF-κB target genes , 2001, Nature.
[45] M. Costas,et al. TNF-α enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B , 2006, Oncogene.
[46] S. M. McFarlane,et al. Differential activation of nuclear factor‐κB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly , 2002, FEBS letters.
[47] S. Park,et al. Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. , 2001, Biochemical and biophysical research communications.
[48] L. Tartaglia,et al. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.
[49] B. Aggarwal,et al. Differential activation of the nuclear factor-kappa B by TNF muteins specific for the p60 and p80 TNF receptors. , 1996, Journal of immunology.
[50] L. Pfeffer,et al. NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.
[51] H. Loetscher,et al. Tumor necrosis factor receptors-structure and function , 1992, Immunologic research.
[52] David Baltimore,et al. Two Pathways to NF-κB , 2002 .
[53] K. Umezawa,et al. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[54] A. Kornblihtt,et al. Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells , 2005, Molecular and Cellular Biology.
[55] G. Pirianov,et al. Interactions of vitamin D analogue CB1093, TNFα and ceramide on breast cancer cell apoptosis , 2001, Molecular and Cellular Endocrinology.
[56] G. Haegeman,et al. NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. , 2005, Journal of the American Society of Nephrology : JASN.
[57] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.